Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperaldosteronism | 66 | 2024 | 234 | 16.340 |
Why?
|
Adrenalectomy | 41 | 2024 | 339 | 5.190 |
Why?
|
Aldosterone | 38 | 2024 | 870 | 4.490 |
Why?
|
Adrenocortical Adenoma | 12 | 2023 | 48 | 3.880 |
Why?
|
Adrenal Cortex Neoplasms | 7 | 2021 | 162 | 2.080 |
Why?
|
Hypertension | 26 | 2023 | 8431 | 1.840 |
Why?
|
Adrenal Glands | 14 | 2023 | 545 | 1.690 |
Why?
|
Acute Kidney Injury | 13 | 2024 | 1941 | 1.390 |
Why?
|
G Protein-Coupled Inwardly-Rectifying Potassium Channels | 8 | 2023 | 64 | 1.130 |
Why?
|
Adrenal Gland Neoplasms | 6 | 2023 | 735 | 1.120 |
Why?
|
Adenoma | 9 | 2023 | 2167 | 1.050 |
Why?
|
Taiwan | 20 | 2021 | 493 | 1.000 |
Why?
|
Hydrocortisone | 9 | 2023 | 1809 | 0.980 |
Why?
|
Yttrium Radioisotopes | 2 | 2021 | 94 | 0.890 |
Why?
|
Interleukin-18 | 1 | 2022 | 248 | 0.780 |
Why?
|
Cushing Syndrome | 1 | 2020 | 249 | 0.660 |
Why?
|
Otoscopy | 1 | 2018 | 35 | 0.630 |
Why?
|
Diastole | 3 | 2020 | 791 | 0.610 |
Why?
|
Renal Dialysis | 7 | 2020 | 1780 | 0.610 |
Why?
|
Embolization, Therapeutic | 3 | 2021 | 1376 | 0.570 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2024 | 2216 | 0.560 |
Why?
|
Ear Diseases | 1 | 2018 | 170 | 0.560 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2014 | 72 | 0.500 |
Why?
|
Salvage Therapy | 1 | 2021 | 1269 | 0.480 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2020 | 2044 | 0.470 |
Why?
|
Hemofiltration | 1 | 2013 | 57 | 0.440 |
Why?
|
Liver Transplantation | 1 | 2023 | 2110 | 0.430 |
Why?
|
Uremia | 1 | 2013 | 200 | 0.420 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2016 | 965 | 0.400 |
Why?
|
Intracranial Pressure | 1 | 2013 | 327 | 0.380 |
Why?
|
Otolaryngology | 1 | 2018 | 644 | 0.380 |
Why?
|
Creatinine | 5 | 2023 | 1903 | 0.380 |
Why?
|
Liver Neoplasms | 3 | 2021 | 4216 | 0.380 |
Why?
|
Glomerular Filtration Rate | 6 | 2024 | 2184 | 0.370 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2220 | 0.370 |
Why?
|
Humans | 96 | 2024 | 739398 | 0.340 |
Why?
|
Renin | 6 | 2023 | 637 | 0.340 |
Why?
|
Education, Medical, Undergraduate | 1 | 2018 | 999 | 0.330 |
Why?
|
Renal Replacement Therapy | 3 | 2021 | 260 | 0.320 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15070 | 0.310 |
Why?
|
Middle Aged | 47 | 2023 | 212863 | 0.280 |
Why?
|
Kidney Failure, Chronic | 6 | 2020 | 2546 | 0.280 |
Why?
|
Mitral Valve | 1 | 2014 | 1483 | 0.270 |
Why?
|
Ventricular Remodeling | 4 | 2023 | 1222 | 0.260 |
Why?
|
Steroid 11-beta-Hydroxylase | 2 | 2022 | 20 | 0.260 |
Why?
|
Ventricular Function, Left | 2 | 2016 | 3620 | 0.260 |
Why?
|
Treatment Outcome | 23 | 2023 | 62693 | 0.260 |
Why?
|
Male | 51 | 2023 | 349022 | 0.260 |
Why?
|
Adult | 38 | 2023 | 213394 | 0.250 |
Why?
|
Female | 49 | 2023 | 378853 | 0.240 |
Why?
|
Retrospective Studies | 29 | 2023 | 76631 | 0.230 |
Why?
|
Hypertrophy, Left Ventricular | 4 | 2023 | 851 | 0.220 |
Why?
|
Hemodynamics | 1 | 2013 | 4197 | 0.220 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2022 | 68 | 0.220 |
Why?
|
Calcium Channels, T-Type | 1 | 2022 | 34 | 0.220 |
Why?
|
Clinical Competence | 1 | 2018 | 4671 | 0.210 |
Why?
|
Cerebral Hemorrhage | 1 | 2013 | 2627 | 0.200 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3344 | 0.200 |
Why?
|
Prospective Studies | 13 | 2024 | 53037 | 0.200 |
Why?
|
Renal Insufficiency | 2 | 2022 | 803 | 0.200 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2022 | 11699 | 0.200 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6726 | 0.190 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4035 | 0.190 |
Why?
|
Echocardiography | 6 | 2023 | 5098 | 0.190 |
Why?
|
Spironolactone | 2 | 2021 | 378 | 0.190 |
Why?
|
Adrenal Cortex Function Tests | 1 | 2019 | 13 | 0.180 |
Why?
|
Radiation Pneumonitis | 1 | 2020 | 104 | 0.180 |
Why?
|
Aged | 31 | 2023 | 162698 | 0.180 |
Why?
|
Blood Specimen Collection | 3 | 2021 | 246 | 0.180 |
Why?
|
Mitochondria, Heart | 1 | 2021 | 248 | 0.180 |
Why?
|
Hearing Aids | 1 | 2020 | 56 | 0.180 |
Why?
|
Radiopharmaceuticals | 2 | 2020 | 2687 | 0.180 |
Why?
|
Cohort Studies | 7 | 2024 | 40389 | 0.170 |
Why?
|
Captopril | 1 | 2019 | 271 | 0.170 |
Why?
|
Pericardium | 1 | 2023 | 665 | 0.170 |
Why?
|
Brachial Artery | 1 | 2020 | 370 | 0.170 |
Why?
|
Obesity, Abdominal | 1 | 2021 | 360 | 0.160 |
Why?
|
Specimen Handling | 2 | 2020 | 692 | 0.160 |
Why?
|
Adosterol | 1 | 2017 | 5 | 0.160 |
Why?
|
Aftercare | 1 | 2024 | 858 | 0.150 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2020 | 2185 | 0.150 |
Why?
|
Echocardiography, Transesophageal | 1 | 2023 | 1128 | 0.150 |
Why?
|
Patient Positioning | 1 | 2019 | 322 | 0.140 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1793 | 0.140 |
Why?
|
GPI-Linked Proteins | 1 | 2018 | 433 | 0.140 |
Why?
|
Risk Factors | 13 | 2024 | 71974 | 0.140 |
Why?
|
DNA, Mitochondrial | 1 | 2021 | 804 | 0.140 |
Why?
|
Antihypertensive Agents | 3 | 2023 | 2039 | 0.140 |
Why?
|
Health Status Indicators | 2 | 2012 | 969 | 0.140 |
Why?
|
Prevalence | 6 | 2023 | 15153 | 0.140 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2021 | 1238 | 0.130 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1820 | 0.130 |
Why?
|
Consensus | 3 | 2021 | 2913 | 0.130 |
Why?
|
Angiography | 1 | 2020 | 1634 | 0.130 |
Why?
|
Cardiomegaly | 1 | 2018 | 620 | 0.130 |
Why?
|
Proton Pump Inhibitors | 1 | 2020 | 519 | 0.130 |
Why?
|
Metabolic Diseases | 1 | 2021 | 658 | 0.130 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2018 | 290 | 0.120 |
Why?
|
Prognosis | 9 | 2021 | 28901 | 0.120 |
Why?
|
Bundle-Branch Block | 1 | 2016 | 270 | 0.120 |
Why?
|
Venous Thrombosis | 1 | 2023 | 1232 | 0.120 |
Why?
|
Heart Failure | 3 | 2023 | 10793 | 0.120 |
Why?
|
Mutation | 7 | 2023 | 29658 | 0.120 |
Why?
|
Radionuclide Imaging | 1 | 2017 | 2028 | 0.110 |
Why?
|
Hearing Loss | 1 | 2020 | 759 | 0.110 |
Why?
|
Stroke Volume | 2 | 2016 | 4941 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5702 | 0.100 |
Why?
|
Hospitals | 2 | 2023 | 3916 | 0.100 |
Why?
|
Automation | 1 | 2014 | 584 | 0.100 |
Why?
|
Observer Variation | 2 | 2016 | 2589 | 0.100 |
Why?
|
Overweight | 1 | 2023 | 2355 | 0.100 |
Why?
|
Diabetic Nephropathies | 1 | 2018 | 981 | 0.100 |
Why?
|
Sepsis | 2 | 2018 | 2571 | 0.100 |
Why?
|
Atrial Fibrillation | 2 | 2020 | 5003 | 0.100 |
Why?
|
Ankle Brachial Index | 2 | 2022 | 154 | 0.100 |
Why?
|
Educational Measurement | 1 | 2018 | 1205 | 0.100 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1673 | 0.090 |
Why?
|
Myocardial Contraction | 1 | 2016 | 1585 | 0.090 |
Why?
|
Kidney Function Tests | 3 | 2022 | 681 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2851 | 0.090 |
Why?
|
Alleles | 1 | 2021 | 6942 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6516 | 0.090 |
Why?
|
Disease Management | 2 | 2021 | 2448 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15036 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 9812 | 0.090 |
Why?
|
Receptors, Mineralocorticoid | 2 | 2021 | 164 | 0.080 |
Why?
|
Time Factors | 7 | 2021 | 40050 | 0.080 |
Why?
|
Incidence | 7 | 2020 | 20913 | 0.080 |
Why?
|
Comorbidity | 6 | 2020 | 10362 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2018 | 3194 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2116 | 0.080 |
Why?
|
Aged, 80 and over | 11 | 2020 | 57650 | 0.080 |
Why?
|
Statistics, Nonparametric | 3 | 2019 | 2881 | 0.080 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2030 | 0.080 |
Why?
|
Intensive Care Units | 3 | 2016 | 3672 | 0.080 |
Why?
|
Liver | 1 | 2023 | 7449 | 0.080 |
Why?
|
RNA, Messenger | 1 | 2022 | 13002 | 0.080 |
Why?
|
Fibroblasts | 1 | 2018 | 4137 | 0.080 |
Why?
|
Risk Assessment | 8 | 2021 | 23294 | 0.080 |
Why?
|
Critical Illness | 3 | 2021 | 2656 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3858 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2023 | 19811 | 0.070 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2019 | 1806 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20055 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2022 | 38942 | 0.070 |
Why?
|
Blood Glucose | 1 | 2020 | 6237 | 0.070 |
Why?
|
Community-Acquired Infections | 1 | 2010 | 463 | 0.070 |
Why?
|
Antitubercular Agents | 1 | 2014 | 1311 | 0.070 |
Why?
|
Hospital Mortality | 6 | 2018 | 5305 | 0.070 |
Why?
|
Internet | 1 | 2018 | 3048 | 0.070 |
Why?
|
Societies, Medical | 1 | 2017 | 3739 | 0.060 |
Why?
|
Body Mass Index | 1 | 2023 | 12655 | 0.060 |
Why?
|
Myocardium | 1 | 2018 | 4788 | 0.060 |
Why?
|
Pilot Projects | 2 | 2019 | 8275 | 0.060 |
Why?
|
Databases, Factual | 4 | 2020 | 7690 | 0.060 |
Why?
|
Biological Assay | 2 | 2018 | 653 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3029 | 0.060 |
Why?
|
Abdomen | 1 | 2009 | 1104 | 0.060 |
Why?
|
Fibrosis | 2 | 2022 | 2024 | 0.060 |
Why?
|
Veins | 2 | 2018 | 767 | 0.060 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 694 | 0.060 |
Why?
|
Bacteremia | 1 | 2010 | 957 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2018 | 3517 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2018 | 10455 | 0.050 |
Why?
|
MicroRNAs | 1 | 2018 | 3712 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8400 | 0.050 |
Why?
|
Laparoscopy | 1 | 2014 | 2091 | 0.050 |
Why?
|
Propensity Score | 2 | 2019 | 1749 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9782 | 0.050 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2023 | 647 | 0.050 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 1 | 2020 | 66 | 0.050 |
Why?
|
Tuberculosis | 1 | 2014 | 1892 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2012 | 2140 | 0.050 |
Why?
|
Cytochromes c | 1 | 2021 | 180 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2019 | 21694 | 0.050 |
Why?
|
Staphylococcal Infections | 1 | 2010 | 1403 | 0.050 |
Why?
|
Liver Circulation | 1 | 2020 | 162 | 0.050 |
Why?
|
Obesity | 1 | 2023 | 12643 | 0.050 |
Why?
|
Cosyntropin | 1 | 2020 | 33 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2021 | 5058 | 0.050 |
Why?
|
Catheters | 1 | 2023 | 419 | 0.050 |
Why?
|
Cystatin C | 1 | 2021 | 250 | 0.050 |
Why?
|
Hyperplasia | 1 | 2023 | 1181 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 24714 | 0.040 |
Why?
|
Catheterization | 2 | 2017 | 1466 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 977 | 0.040 |
Why?
|
Diuretics | 1 | 2022 | 590 | 0.040 |
Why?
|
Retreatment | 1 | 2020 | 603 | 0.040 |
Why?
|
Caspase 3 | 1 | 2021 | 758 | 0.040 |
Why?
|
Critical Care | 1 | 2011 | 2624 | 0.040 |
Why?
|
Cytokine Receptor gp130 | 1 | 2018 | 66 | 0.040 |
Why?
|
Thrombectomy | 1 | 2023 | 673 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 925 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2020 | 740 | 0.040 |
Why?
|
Germany | 1 | 2019 | 853 | 0.040 |
Why?
|
ROC Curve | 2 | 2018 | 3526 | 0.040 |
Why?
|
Survival Analysis | 3 | 2018 | 10247 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12328 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15511 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 21863 | 0.040 |
Why?
|
Phlebotomy | 1 | 2018 | 142 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1156 | 0.040 |
Why?
|
Stroke | 1 | 2019 | 9898 | 0.040 |
Why?
|
Kidney | 2 | 2022 | 7144 | 0.040 |
Why?
|
Microspheres | 1 | 2019 | 778 | 0.030 |
Why?
|
Phlebography | 1 | 2017 | 333 | 0.030 |
Why?
|
Hormones | 1 | 2020 | 880 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 630 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2021 | 3146 | 0.030 |
Why?
|
Echocardiography, Doppler | 1 | 2019 | 934 | 0.030 |
Why?
|
Ontario | 1 | 2016 | 375 | 0.030 |
Why?
|
Siblings | 1 | 2019 | 853 | 0.030 |
Why?
|
Area Under Curve | 1 | 2019 | 1655 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2021 | 2022 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2021 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2019 | 2270 | 0.030 |
Why?
|
Fasting | 1 | 2020 | 1587 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1778 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 21507 | 0.030 |
Why?
|
Blood Pressure | 2 | 2023 | 8554 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2023 | 2155 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2378 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1004 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2084 | 0.030 |
Why?
|
Surgery, Computer-Assisted | 1 | 2021 | 1008 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2296 | 0.030 |
Why?
|
Polysomnography | 1 | 2019 | 1765 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4182 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1625 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2904 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2020 | 1920 | 0.030 |
Why?
|
APACHE | 1 | 2012 | 277 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7136 | 0.030 |
Why?
|
Age of Onset | 1 | 2018 | 3263 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12948 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4983 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6452 | 0.020 |
Why?
|
Young Adult | 4 | 2020 | 56255 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6310 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1801 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3562 | 0.020 |
Why?
|
Potassium | 1 | 2014 | 1337 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15194 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2671 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 13816 | 0.020 |
Why?
|
Population Surveillance | 1 | 2020 | 2629 | 0.020 |
Why?
|
Disease Progression | 2 | 2018 | 13237 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5948 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 2018 | 1471 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3698 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1175 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4582 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3564 | 0.020 |
Why?
|
Observation | 1 | 2009 | 312 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11347 | 0.020 |
Why?
|
Mass Screening | 1 | 2023 | 5265 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15987 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4211 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9846 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7726 | 0.020 |
Why?
|
Insulin | 1 | 2020 | 6569 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10398 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3510 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9734 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2009 | 1186 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12237 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8039 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13880 | 0.010 |
Why?
|
Animals | 3 | 2021 | 168368 | 0.010 |
Why?
|
Mice | 2 | 2021 | 81002 | 0.010 |
Why?
|
Contrast Media | 1 | 2016 | 5293 | 0.010 |
Why?
|
Electrocardiography | 1 | 2016 | 6426 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18349 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9714 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 19220 | 0.010 |
Why?
|
Survivors | 1 | 2012 | 2280 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9609 | 0.010 |
Why?
|
Adolescent | 2 | 2022 | 85405 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13402 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23355 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35326 | 0.010 |
Why?
|